An Interactional Approach for Pharmacopsychologists and Psychologists: Gender Concerns

Journal of Clinical Psychology in Medical Settings

Volumn 6, Issue 1, 1999, Pages 39-61

  Ackerman, Rosalie J ^a  

^a Research and Development Division   (United States)

Author keywords

Gender; Health psychology; Prescribing; Psychotropic medication

Indexed keywords

EID: 2342506629     PISSN: 10689583     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026203314062     Document Type: Article

References (91)

1. Abernathy, D. R., Greenblatt, D. J., & Shader, R. I. (1984). Imipramine disposition in users of oral contraceptive steroids. Clinical Pharmacology & Therapeutics, 35, 792-797.
2. Ackerman, R. J. (1996). Gender concerns in prescription privileges. Paper presented at the 104th annual meeting of the American Psychological Association, Toronto, CA.
3. Ackerman, R. J. (1997). An interactional approach for pharmacopsychologists and psychologists: Gender concerns. Paper presented at the 105th annual meeting of the American Psychological Association, Chicago, IL.
4. Ackerman, R. J., & Banks, M. E. (1994). Feminist perspectives on issues of psychologists and prescription privileges. Paper presented at American Psychological Association Division of Psychology of Women (Division 35) Executive Committee, Madison, WI.
5. Ackerman, R. J., & Banks, M. E. (1997). Sociocultural concerns in pharmacopsychology: Prescription privileges. (manuscript in review)
6. Ambrosini, P. J., Bianchi, M. D., Rabinovich, H., & Elia, J. (1993). Antidepressant treatment in children and adolescents, I. Affective disorders. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 1-6.
7. Anderson, N. B., & Armstead, C. A. (1995). Toward understanding the association of socioeconomic status and health: A new challenge for the biopsychosocial approach. Psychosomatic Medicine, 57, 213-225.
8. Anderson, N. B., & McNeilly, M. (1991). Age, gender, and ethnicity as variables in psychophysiological assessment: Sociodemographics in context. Psychological Assessment, 3, 376-384.
9. Areias, M. E., Kumar, R., Barros, H., & Figueiredo, E. (1996). Comparative incidence of depression in women and men, during pregnancy and after childbirth. Validation of the Edinburgh Postnatal Scale in Portuguese mothers. British Journal of Psychiatry, 169, 30-35.
10. Armitage, R., Emslie, G., & Rintelmann, J. (1997). The effect of fluoxetine on sleep EEG in childhood depression: a preliminary report. Neuropsychopharmacology, 17, 241-245.
11. Badger, T. A. (1996). Family members' experiences living with members with depression. Westem Journal of Research 18, 149-171.
12. Ballenger, J. C., Wheadon, D. E., Steiner, M., Bushnell, W., & Gergel, I. P. (1998). Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. American Journal of Psychiatry, 155, 36-42.
13. Banks, M. E. (1996a). Medication concerns for African American women: Where's the research? Paper presented at the 104th annual meeting of the American Psychological Association, Toronto, CA.
14. Banks, M. E. (1996b), Psychotropic medications: Ethnic and racial concerns. Paper presented at the 104th annual meeting of the American Psychological Association, Toronto, CA.
15. Barbee, E. L. (1992). African American women and depression: A review and critique of the literature. Archives of Psychiatric Nursing, 6, 257-265.
16. Barnet, B., Joffe, A., Duggan, A. K., Wilson, M. D., & Repke, J. T. (1996). Depressive symptoms, stress, and social support in pregnant and postpartum adolescents. Archives of Pediatric Adolescent Medicine, 150, 64-69.
17. Bhatia, S. C., & Bhatia, S. K. (1997). Major depression: Selecting safe and effective treatment. American Family Physician, 55, 1683-1694.
18. Brown, R. T. (1997, August). Psychological and pharmacological therapies in children. Paper presented at the 105th annual meeting of the American Psychology Association, Chicago, IL.
19. Buist, A., & Janson, H. (1995). Effect of exposure to dothiepin and northiaden in breast milk on child development. British Journal of Psychiatry, 167, 370-373.
20. Cadieux, R. J. (1993). Geriatric psychopharmacology. Postgraduate Medicine, 93, 281-282, 285-288, 294-296, 301.
21. Catterson, M. L., Preskorn, S. H., & Martin, R. L. (1997). Pharmacodynamic and pharmacokinetic considerations in geriatric psychopharmacology. Psychiatric Clinics of North American, 20, 205-218.
22. Chisholm, C. A., & Kuller, J. A. (1997). A guide to the safety of CNS-active agents during breast feeding. Drug Safety, 17, 127-142.
23. Comas-Díaz, L. & Jacobsen, F. (1995). Psychopharmacology for women of color: An empowering approach. Women & Therapy, 16, 85-112.
24. Emslie, G. J., Rush, J., Weinberg, W. A., Kowatch, R. A., Hughes, C. W., Carmody, T., & Rintelmann, J. (1997). A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Archives of General Psychiatry, 54, 1031-1037.
25. Feiger, A., Kiev, A., Shrivastava, R. M., Wisselink, P. G., & Wilcox, C. S. (1996). Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. Journal of Clinical Psychiatry, 57(Supplement 2), 53-62.
26. Fisher, R. L., & Fisher, S. (1996). Antidepressants for children. Is scientific support necessary? Journal of Nervous and Mental Disease, 184, 99-102.
27. Flaherty, B., & Krenzelok, E. P. (1997). Neonatal lithium toxicity as a result of maternal toxicity. Veterinary Human Toxicology, 39, 92-93.
28. Gadow, K. D. (1991). Clinical issues in child and adolescent psychopharmacology: Perspectives on child and adolescent therapy. Journal of Consulting & Clinical Psychology, 59, 842-852.
29. Gallant, S. J., Hamilton, J. A., Popiel, D. A., Morokoff, P. J., & Chakraborty, P. K. (1991). Daily moods and symptoms: Effects of awareness of study focus, gender, menstrual-cycle phase, and day of the week. Health Psychology, 10, 180-189.
30. Goodnick, P. J., & Schorr-Cain, C. B. (1991). Lithium pharmacokinetics. Psychopharmacology Bulletin, 27, 475-491.
31. Greenhill, L. L., & Setterberg, S. (1993). Pharmacotherapy of disorders of adolescents. Psychiatric Clinics of North America, 16, 793-814.
32. Greenhill, L. L., & Waslick, B. (1997). Management of suicidal behavior in children and adolescents. Psychiatric Clinics of North America, 20, 641-666.
33. Halbreich, U. (1997). Role of estrogen in postmenopausal depression. Neurology, 48(Suppl. 7), S16-S19.
34. Hall, C. C. I. (1997). Cultural malpractice. American Psychologist, 52, 642-651.
35. Hamilton, J. A. (1995). Sex and gender as critical variables in psychotropic drug research. In C. V. Willie, P. P. Rieker, B. M. Kramer, & B. S. Brown (Eds.), Mental health, racism, and sexism (pp. 297-349). Pittsburgh: University of Pittsburgh Press.
36. Hamilton, J. A., Gallant, S., & Lloyd, C. (1989). Evidence for a menstrual-linked artifact in determining rates of depression. Journal of Nervous and Mental Disorders, 177, 359-65.
37. Hamilton, J. A., & Jensvold, M. J. (1995a). Introduction: Feminist psychopharmacology. Women & Therapy, 16, 1-7.
38. Hamilton, J. A., & Jensvold, M. J. (1995b). Sex and gender as critical variables in feminist psychopharmacology research and pharmacotherapy. Women & Therapy, 16, 9-30.
39. Jensvold, M. J., Halbreich, U., & Hamilton, J. A. (Eds.). (1996). Psychopharmacology of women: Sex, gender, and hormonal considerations. Washington, DC: American Psychiatric Press.
40. Jensvold, M. J., Reed, K., Jarrett, D. B., & Hamilton, J. A. (1992). Menstrual cycle-related depressive symptoms treated with variable antidepressant dosage. Journal of Women's Health, 1, 109-115.
41. Jicks, S. S., Dean, A. D., & Jicks, H. (1995). Antidepressants and suicide. British Medical Journal, 310, 215-218.
42. Kimmel, S., Gonsalves, L., Youngs, D., & Gidwani, G. (1992). Fluctuating levels of antidepressants premenstrually. Journal of Psychosomatic Obstetrics and Gynecology, 13, 277-280.
43. Kulin, N. A., Pastuszak, A., Sage, S. R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A. K., Cook, L., Brochu, J., Rieder, M., & Koren, G. (1998). Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: A prospective controlled multicenter study. Journal of the American Medical Association, 279, 609-610.
44. Leathers, S. J., Kelley, M. A., & Richman, J. A. (1997). Postpartum depressive symptomatology in new mothers and fathers: Parenting, work, and support. Journal of Nervous an Mental Disorders, 185, 129-139.
45. Leibenluft, E. (1996). Women with bipolar illness: Clinical and research issues. American Journal of Psychiatry, 153, 163-173.
46. Leibenluft, E. (1997). Issues in the treatment of women with bipolar illness. Journal of Clinical Psychiatry, 58 (Suppl. 15), 5-11.
47. Leibenluft, E., Fiero, P. L., & Rubinow, D. R. (1994). Effects of the menstrual cycle on dependent variables in mood disorder research. Archives of General Psychiatry, 51, 761-781.
48. Lessmeier, T. J., Gamperling, D., Johnson-Liddon, V., Fromm, B. S., Steinman, R. T., Meissner, M. D., & Lehman, M. H. (1997). Unrecognized paroxysmal supraventricular tachycardia: Potential for misdiagnosis as panic disorder. Archives of Internal Medicine, 157, 537-543.
49. Lewis-Hall, F. C., Wilson, M. G., Tepner, R. G., Koke. S. C. (1997). Fluoxetine vs. tricyclic antidepressants in women with major depressive disorder. Journal of Women's Health 6, 337-343.
50. Lin, K-M., & Poland, R. E. (1993). Ethnicity , culture, and psychopharmacology. In F. E. Bloom & D. J. Kupfer (Eds.), Psychopharmacology: The fourth generation of progress. New York: Raven.
51. Livingston, R. L., Zucker, D. K., Isenberg, K., & Wetzel, R. D. (1983). Tricyclic antidepressants and delirium. Journal of Clinical Psychiatry, 44, 173-176.
52. Llewellyn, A., M., Stowe, Z. N., & Nemeroff, C. B. (1997). Depression during pregnancy and the puerperium. Journal of Clinical Psychiatry, 58 (Suppl. 15), 26-32.
53. Malone, K. M. (1997). Pharmacotherapy of affectively ill suicidal patients. Psychiatric Clinics of North America, 20, 613-625.
54. Marsh, M. (1995). Feminist psychopharmacology: An aspect of feminist psychiatry. Women & Therapy, 16, 73-84.
55. Maynard, C., Every, N. R., Martin, J. S., Kudenchuk, P. J., & Weaver, W. D. (1997). Association of gender and survival in patients with acute myocardial infarction. Archives of Internal Medicine, 157, 1379-1384.
56. McGrath, E., Keita, G. P., Strickland, B. R., & Russo, N. F. (1990). Women and depression: Risk factors and treatment issues: Final Report of APA national task force on women and depression. Washington, DC: American Psychological Association.
57. Montejo-Gonzalez, A. L., Llorca, G., Izquierdo, J. A., Ledesma, A., Bousono, M., Calcedo, A., Carrasco, J. L., Ciudad, J., Daniel, E., De la Gandara, J., Derecho, J., Franco, M., Gomez, M. J., Macias, J. A., Martin, T., Perez, V., Sanchez, J. M., Sanchez, S., & Vicens, E. (1997). SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and in a prospective, multicenter, and descriptive clinical study of 344 patients. Journal of Sex and Marital Therapy, 23, 176-194.
58. Oxman, T. E. (1996). Antidepressants and cognitive impairment in the elderly. Journal of Clinical Psychiatry, 57 (Suppl. 5), 38-44.
59. Pagliaro, L. A., & Pagliaro, A. M. (Eds.). (1995). Problems in pediatric drug therapy (3rd ed). Hamilton, IL: Drug Intelligence Publications.
60. Pagliaro, L. A., & Pagliaro, A. M. (Eds.), (1996). Substance use among children and adolescents: Its nature, extent, an effects from conception to adulthood. New York: Wiley.
61. Pagliaro, L. A., & Pagliaro, A. M. (1998). The pharmacologic basis of psychotherapeutics: An introduction for psychologists. Washington, DC: Brunner/Mazel Taylor & Francis.
62. Pariser, S. F., Nasrallah, H. A., & Gardner, D. K. (1997). Postpartum mood disorders: Clinical perspectives. Journal of Women's Health, 6, 421-434.
63. Pearlstein, T. B., Stone, A. B., Lund, S. A., Scheft, H., Zlotnick, C., & Brown, W. A. (1997). Comparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorder. Journal of Clinical Psychopharmacology, 17, 261-266.
64. Phillips, L. H., & O'Hara, M. W. (1991). Prospective study of postpartum depression: 4 1/2-year follow-up of women and children. Journal of Abnormal Psychology, 100, 151-155.
65. Piazza, L. A., Markowitz, J. C., Kocsis, J. H., Leon, A. C., Portera, L., Miller, N. L., & Adler, D. (1997). Sexual functioning in chronically depressed patients treated with SSRI antidepressants: A pilot study. American Journal of Psychiatry, 154, 1757-1759.
66. Pitt, B. M. (1988). Lofepramine in the elderly. International Journal of Clinical Psychopharmacology, 3, 49-54.
67. Post, L. L. (1994). Sexual side effects of psychiatric medications in women [Letter]. American Journal of Psychiatry, 151, 1247.
68. Raskin, A., & Crook, T. H. (1975). Antidepressants in Black and White inpatients. Archives of General Psychiatry, 32, 643-649.
69. Rosenberg, L., Adams-Campbell, L., & Palmer, J. R. (1995). The Black women's health study: A follow-up study for causes and preventions of illness. Journal of American Medical Women Association, 50, 56-58.
70. Rosser, S. V. (1994). Women's health - Missing from U. S. medicine. Indianapolis: Indiana University Press.
71. Rudorfer, M. V. (1993). Pharmacokinetics of psychotropic drugs in special populations. Journal of Clinical Psychiatry, 54 (Suppl.), 50-56.
72. Rudorfer, M. V., & Robins, E. (1982). Amitriptyline overdose: Clinical effects on tricyclic antidepressant plasma levels. Journal of Clinical Psychiatry, 43, 457-460.
73. Ryan, N. (1992). The pharmacologic treatment of child and adolescent depression. Psychiatric Clinics of North America, 15, 29-40.
74. Schneider, L. S., Small, G. W., Hamilton, S. H., Bystritsky, A., Nemeroff, C. B., Meyers, B. S. (1997). Estrogen replacement and response to fluoxetine in a multicenter geriatric depression trial. Fluoxetine Collaborative Study Group. American Journal of Geriatric Psychiatry, 5, 97-106.
75. Shelton, R. C., Davidson, J., Yonkers, K. A., Koran, L., Thase, M. E., Pearlstein, T., & Halbreich, U. (1997). The undertreatment of dysthymia. Journal of Psychiatry, 58, 59-65.
76. Singer, M. A., Anglin, T. M., Song, L. Y., & Lunghofer, L. (1995). Adolescents' exposure to violence and associated symptoms of psychological trauma. Journal of the American Medical Association 273, 477-482.
77. Sommers-Flanagan, J., & Sommers-Flanagan, R. (1996). Efficacy of antidepressant medication with depressed youth: What psychologists should know. Professional Psychology, 27, 145-153.
78. Strickland, T. L., Lin, K-M., Fu, P., Andersen, D., & Zheng, Y. (1995). Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biological Psychiatry, 37, 325-330.
79. Strickland, T. L., Ranganath, V., Lin, K., Poland, R. E., Mendoza, R., & Smith, M. W. (1991). Psychopharmacologic considerations in the treatment of Black American populations. Psychopharmacology Bulletin, 27, 441-448.
80. Strickland, T. L., Stein, R., Lin, K-M., Risby, E., & Fong, R. (1997). The pharmacologic treatment of anxiety and depression in African Americans: Considerations for the general practitioner. Archives of Family Medicine, 6, 371-375.
81. Sylvester, C. (1993). Psychopharmacology of disorders in children. Psychiatric Clinics of North America, 16, 779-791.
82. Thompson, J. (1995). Racial, ethnie, and mental illness stereotypes: Cognitive process and behavioral effects. In C. V Willie, P. P. Rieker, B. M. Kramer, & B. S. Brown (Eds.), Mental health, racism, and sexism (pp. 119-147). Pittsburgh: University of Pittsburgh Press.
83. Thorogood, M., Cowen, P., Mann, J., Murphy, M., & Vessey, M. (1992). Fatal myocardial infarction and use of psychotropic drugs in young women. Lancet, 340, 1067-1068.
84. Thurber, S., Ensign, J., Punnett, A. F., & Welter, K. (1995). A meta-analysis of antidepressant outcome studies that involve children and adolescents. Journal of Clinical Psychology, 51, 340-345.
85. Wilens, T. E. Biederman, J., Baldessarini, R. J., Geller, B., Schleifer, D., Spencer, T J., Birmaher, B., & Goldblatt, A. (1996). Cardiovascular effects of therapeutic doses of tricyclic antidepressants in children and adolescents. Journal of the American Academy of Children and Adolescents Psychiatry, 35, 1491-1501.
86. Wisner, K. L., Perel, J. M., & Findling, R. L. (1996). Antidepressant treatment during breast-feeding. American Journal of Psychiatry, 153, 1132-1137.
87. Wyatt, G. E. (1991). Examining ethnicity versus race in AIDS related sex research. Social Science Medicine, 33, 37-45.
88. Yonkers, K. A., & Hamilton, J. A. (1996). Sex differences in pharmacokinetics. Part 2: Effects on selected psychotropics. In M. J. Jensvold, U. Halbreich, & J. A. Hamilton (Eds.), Psychopharmacology of women: Sex, gender, and hormonal considerations. Washington, DC: American Psychiatric Press.
89. Yonkers, K. A., Kando, J. C., Cole, J. O., & Blumenthal, S. (1992). Gender differences in pharmacokinetics and pharmacodynamics in psychotropic medication. American Journal of Psychiatry, 149, 587-595.
90. Young, R. C. (1997). Bipolar mood disorders in the elderly. Psychiatric Clinics of North America, 20, 121-136.
91. Zeiger, V. E., Clayton, P. J., & Biggs, J. T. (1977). A comparison study of amitriptyline and nortriptyline with plasma levels. Archives of General Psychiatry, 34, 607-612.